• Call us : (202-800-3001)
  • Email us: info@whistleblowerlaws.com
WhistleblowerLaws

The Source for Whistleblowers, Journalists, Legislators & Academics

Toggle menu

Skip to content
  • Home
  • Who Are We
    • Our Successes
    • Justin S. Brooks
    • Reuben Guttman
    • Traci Buschner
    • Dan Guttman
    • Judge Nancy Gertner (Ret.)
    • Dr. Caroline Poplin
    • Elizabeth H. Shofner
    • Aaron Welo
  • Whistleblowing
    • Whistleblower Expectations
    • Whistleblower Concerns
    • Whistleblower Protections
    • Whistleblower Rewards and Lawsuit Damages
    • What do I do if I think fraud is being committed?
    • Types of Fraud
      • Pharmaceutical Fraud
      • Medicare and Medicaid Fraud
      • Securities Fraud
      • Fraudulent Loans and Grants
      • Education Fraud
      • Defense Contractor Fraud
      • Federal Government Contractor Fraud
    • Getting Started
  • Contact us
  • FAQs
  • Resource Center
    • False Claims Acts
    • False Claims Act and Whistleblower News
    • Whistleblower Articles

Whistleblower News & information

16 Mar
0

Big Pharma’s Sugared Pills

Staff
Whistleblower News

By Andrew Jack, Financial Times
Published March 11, 2011

Read it here.

Or if you have a FT subscription: http://www.ft.com/cms/s/0/ae7099a0-49bc-11e0-acf0-00144feab49a.html#axzz1GnR32mEN

Previous Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Important Whistleblower Information

  • VIDEO: Getting Started as a Whistleblower

  • Whistleblower Expectations

  • Whistleblowing

  • What makes someone a whistleblower?

  • If I Witness Corporate Misconduct, What Should I Do?

  • False Claims Act

  • Whistleblower Protections

  • Types of Fraud

Can’t find what you’re looking for?

Whistleblower News

  • February 6, 2023 CLE: Demand Letters and Pre-Complaint Settlement
  • July 25, 2022 Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements
  • November 8, 2021 Whistleblowers and fears of losing funds key to enforcing U.S. vaccine rules
  • September 20, 2021 Reuben A. Guttman, District of Columbia Fellow, Co-Publishes “Pretrial Advocacy”
  • September 15, 2021 Book: New Pretrial Advocacy Book Addresses New Norms in Transformed Field of Litigation

CONTACT US

Send Us your Request

WHAT NOT TO DO

We will investigate about your case

EXPERIENCE AND RESOURCES

We will fight your case in court

footerlogo

WhistleblowerLaws.com provides the latest in information, Legal developments, new and free conslultation to those considering blowing the whistle on fraud.

Getting Started
Whistlbower Basics
Whistlbower Protections

LATEST NEWS

  • CLE: Demand Letters and Pre-Complaint Settlement

  • Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements

  • Whistleblowers and fears of losing funds key to enforcing U.S. vaccine rules

Contact Us

  • 202-800-3001
  • info@whistleblowerlaws.com
  • www.whistleblowerlaws.com
  • Washington DC Office: NEW!
    Embassy Row District
    1509 22nd Street, NW
    Washington, D.C. 20037
  • Mon to Sat - 9:00am to 6:00pm
    (Appointments recommended)

 

 

 
 
 
Pennsylvania Office: NEW!
450 N. Narberth Avenue
Suite 201
Narberth, PA 19072
Tel: (610) 547-9556

Copyright © 2022 WhistleblowerLaws.com. All rights reserved.